Cargando…
Opportunities for PET to deliver clinical benefit in cancer: breast cancer as a paradigm
The glucose analogue fluorodeoxyglucose (FDG) has demonstrated enhanced uptake in the majority of tumours as a result of increased uptake and fixation by phosphorylation. It is the most widely used radiotracer in positron emission tomography (PET), being used in >90% of scans, and is useful for d...
| Autores principales: | , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
e-Med
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2904028/ https://www.ncbi.nlm.nih.gov/pubmed/20605761 http://dx.doi.org/10.1102/1470-7330.2010.0020 |